Antioxidants, Redox-Regulated Transcription Factors, and Inflammation

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 403-421

  Winyard, Paul G ^a   Blake, David R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956735106     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60993-X     Document Type: Article

References (103)

1. Abate C., Patel L., Rauscher F.J., and Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249 (1990) 1157-1161
2. Adamson G.M., and Billings R.E. The role of xanthine oxidase in oxidative damage caused by cytokines in cultured mouse hepatocytes. Life Sci. 55 (1994) 1701-1709
3. Alpha-Tocopherol, β-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 (1994) 1029-1035
4. Amstad P.A., Krupitza G., and Cerutti P.A. Mechanism of c-fos induction by active oxygen. Cancer Res. 52 (1992) 3952-3960
5. Auphan N., Didonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-KB activity through induction of IKB synthesis. Science 270 (1995) 286-290
6. Bae I., Smith M.L., Sheikh M.S., Zhan Q.M., Scudiero D.A., Friend S.H., O'Connor P.M., and Fornace A.J. An abnormality in the p53 pathway following gamma-irradiation in many wild-type pS3 human melanoma lines. Cancer Res. 56 (1996) 840-847
7. Barnes P.J. Anti-inflammatory mechanisms of glucocorticoids. Biochem. Soc. Trans. 23 (1995) 940-945
8. Baeuerle P.A., and Henkel T. Function and activation of NF-KB in the immune system. Annu. Rev. immunol. 12 (1994) 141-179
9. Bashir S., Harris G., Denman A.M., Blake D.R., and Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52 (1992) 659-666
10. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1994) 817-827
11. Blake D.R., Winyard P.G., and Marok R. The contribution of hypoxia-reperfusion injury to inflammatory synovitis: The influence of reactive oxygen intermediates on the transcriptional control of inflammation. N.Y. Acad. Sci. 723 (1994) 308-317
12. Brand K., Rogler G., Bartsch A., Knuechel R., Page M., Kaltschmidt C., Baeuerle P.A., and Neumeier D. Nuclear factor-kappa B/Rel is activated in the atherosclerotic lesion. Circulation 92 (1995) 759 [Abstract]
13. Brawn M.K., Chiou W.J., and Leach K.L. Oxidant-induced activation of protein-kinase-C in UC11MG cells. Free Rad. Res. 22 (1995) 23-37
14. Brennan P., and O'Neill L.A.J. Effects of oxidants and antioxidants on nuclear factor KB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta 1260 (1995) 167-175
15. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of IKB- α proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
16. Butcher R.G., Bitensky L., Cashman B., and Chayen J. Differences in the redox balance in human rheumatoid and non-rheumatoid synovial lining cells. Beitr. Path. Bd. 148 (1973) 265-274
17. Cadenas E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 58 (1989) 79-110
18. Chernajovsky Y., Feldmann M., and Maini R.N. Gene therapy of rheumatoid arthritis via cytokine regulation: Future perspectives. Br. Med. Bull. 51 (1995) 503-516
19. Crawford D.R., Schools G.P., Salmon S.L., and Davies K.J.A. Hydrogen peroxide induces the expression of adapt15, a novel RNA associated with polysomes in hamster HA-1 cells. Arch. Biochem. Biophys. 325 (1996) 256-264
20. Didonato J.A., Mercurio F., and Karin M. Phosphorylation of IKBα precedes but is not sufficient for its dissociation from NF-KB. Mol. Cell. Biol. 15 (1995) 1302-1311
21. Drury P.L., Rudge S.R., and Perrett D. Structural requirements for activity of certain "specific" antirheumatic drugs: More than a simple thiol group?. Br. J. Rheumatol. 23 (1984) 100-106
22. Edwards D.R., Murphy G., Reynolds J.J., Whitlam S.E., Docherty A.J.P., Angel P., and Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6 (1987) 1899-1904
23. Fairburn K., Grootveld M., Ward R.J., Abiuka C., Kus M., Williams R.B., Winyard P.G., and Blake D.R. α-Tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease. Clin. Sci. 83 (1992) 657-664
24. Fassbender H.G. Current understanding of rheumatoid arthritis. Inflammation 8 Suppl. (1984) S27-S42
25. Fialkow L., Chan C.K., Rotin D., Grinstein S., and Downey G.P. Activation of the mitogen-activated protein-kinase signaling pathway in neutrophils: Role of oxidants. J. Biol. Chem. 269 (1994) 31234-31242
26. Forman H.J., and Thomas M.J. Oxidant production and bactericidal activity of phagocytes. Annu. Rev. Physiol. 48 (1986) 669-680
27. Fornace A.J., Nebert D.W., Hollander M.C., Luethy J.D., Papathanasiou M., Fargnoli J., and Holbrook N.J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9 (1989) 4196-4203
28. Fraga C.G., Shigenaga M.K., Park J.-W., Degan P., and Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4533-4537
29. Fridovich I. Hypoxia and oxygen toxicity. Adv. Neurol. 26 (1979) 255-259
30. Garciaruiz C., Colell A., Morales A., and Kaplowitz N. Role of oxidative stress generated from the mitochondrial electron-transport chain and mitochondrial glutathione status in loss of mitochondrial-function and activation of transcription factor nuclear factor-kappa-B: Studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48 (1995) 825-834
31. Ghosh S., and Baltimore D. Activation in vitro of NF-KB by phosphorylation of its inhibitor IKB. Nature 344 (1990) 678-682
32. Ghosh G., Van Duyne G., Ghosh S., and Sigler P.B. Structure of NF-KB p50 homodimer bound to a KB site. Nature 373 (1995) 303-310
33. Gravallese E.M., Darling J.M., Ladd A.L., Katz J.N., and Glimcher L.H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum. 34 (1991) 1076-1084
34. Grippo J.F., Holmgren A., and Pratt W.B. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 260 (1985) 93-97
35. Halliwell B. Vitamin C: The key to health or a slow-acting carcinogen?. Redox Rep. 1 (1994) 5-9
36. Halliwell B., and Gutteridge J.M.C. The importance of free radicals and catalytic metal ions in human disease. Mol. Asp. Med. 8 (1985) 89-193
37. Hancock J.T., Maly F.E., and Jones O.T.G. Properties of the superoxide-generating oxidase of B-lymphocyte cell lines: Determination of Michaelis parameters. Biochem. J. 262 (1989) 373-375
38. Handel M.L., Mcmorrow L.B., and Gravallese E.M. Nuclear factor-KB in rheumatoid synovium: Localisation of p50 and p65. Arthritis Rheum. 38 (1995) 1762-1770
39. Harris G., Bashir S., and Winyard P.G. 7,8-Dihydro-8-oxo-2'-deoxyguanosine present in DNA is not simply an artefact of isolation. Carcinogenesis 15 (1994) 411-413
40. Hayashi T., Ueno Y., and Okamato T. Oxidoreductive regulation of nuclear factor KB: Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268 (1993) 11380-11388
41. Heliovaara M., Knekt P., Aaran R.K., Alfthan G., and Aromaa A. Serum antioxi-dants and risk of rheumatoid arthritis. Ann. Rheum. Dis. 53 (1994) 51-53
42. Henney A.M., Wakeley P.R., Davies M.J., Foster K., Hembry R., Murphy G., and Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8154-8158
43. Houglum K., Bedossa P., and Chojkier M. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am. J. Physiol. 267 (1994) G908-G913
44. Jacobson M.D. Reactive oxygen species and programmed cell death. TIBS 21 (1996) 83-86
45. Jarasch E.-D., Bruder G., and Heid H.W. Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol. Scand. 548 Suppl. (1986) 39-46
46. Jessup W., Darley-Usmar V., O'Leary V., and Bedwell S. 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein. Biochem. J. 278 (1991) 163-169
47. Kaltschmidt B., Baeuerle P.A., and Kaltschmidt C. Potential involvement of the transcription factor NF-KB in neurological disorders. Mol. Aspects Med. 14 (1993) 171-190
48. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G.W., Wekerle H., Baeuerle P.A., and Gehrmann J. Transcription factor NF-KB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55 (1994) 99-106
49. Kaltschmidt C., Kaltschmidt B., Henkel T., Stockinger H., and Baeuerle P.A. Selective recognition of the activated form of transcription factor NF-KB by a monoclonal antibody. Biol. Chem. Hoppe-Seyler 376 (1995) 9-16
50. Karin M. The AP-1 complex and its role in transcriptional control by protein kinase C. In: Cohen P., and Foulkes J.G. (Eds). "Molecular Aspects of Cellular Regulation" 6 (1991), Elsevier, Amsterdam 235-253
51. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., and Kollias G. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10 (1991) 4025-4031
52. Keyse S.M., and Emslie E.A. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359 (1992) 644-647
53. Keyse S.M., and Tyrrell R.M. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and WA (365 nm) radiation: Evidence for the involvement of the hydroxyl radical. Carcinogenesis 11 (1990) 787-791
54. Kinne R.W., Boehm S., Iftner T., Aigner T., Vomehm S., Weseloh G., Bravo R., Emmrich F., and Kroczek R.A. Synovial fibroblast-like cells strongly express jun-B and c-fos proto-oncogenes in rheumatoid- and osteoarthritis. Scand. J. Rheumatol. 24 Suppl. 101 (1995) 121-125
55. Kopp E., and Ghosh S. Inhibition of NF-KB by sodium salicylate and aspirin. Science 265 (1994) 956-959
56. Kristal B.S., Kim J.D., and Yu B.P. Tissue-specific susceptibility to peroxyl radical-mediated inhibition of mitochondrial transcription. Redox Rep. 1 (1994) 51-55
57. Kus M.L., Fairburn K., Blake D.R., and Winyard P.G. A vascular basis for free radical involvement in inflammatory joint disease. In: Blake D., and Winyard P.G. (Eds). "Immunopharmacology of Free Radical Species" (1995), Academic Press, London 97-112
58. Lander H.M., Sehajpal P., Levine D.M., and Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150 (1993) 1509-1516
59. Larrick J.W., and Wright S.C. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 4 (1990) 3215-3223
60. Lewis A.J., and Keft A.F. A review on the strategies for the development and application of new anti-arthritic agents. Immunopharmacol. Immunotoxicol. 17 (1995) 607-663
61. Liao F., Andalibi A., Debeer F.C., Fogelman A.M., and Lusis A.J. Genetic control of inflammatory gene induction and NF-KB-like transcription factor activation in response to an atherogenic diet in mice. J. Clin. Invest. 91 (1993) 2572-2579
62. Los M., Schenk H., Hexel K., Baeuerle P.A., Droge W., and Schulze-Osthoff K. IL-2 gene expression and NF-KB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14 (1995) 3731-3740
63. Marok R., Winyard P.G., Coumbe A., Kus M.L., Gaffney K., Mapp P.I., Blades S., Morris C.J., Blake D.R., Kaltschmidt C., and Baeuerle P.A. Activation of the transcription factor NF-KB in the inflamed human synovium. Arthritis Rheum. 39 (1996) 583-591
64. Matthews J.R., Wakasugi N., Virelizier J.-L., Yodoi J., and Hay R.T. Thioredoxin regulates the DNA binding activity of NF-KB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20 (1992) 3821-3830
65. Mccord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312 (1985) 159-163
66. Mckay I.A., Winyard P.G., Leigh I.M., and Bustin S.A. Nuclear transcription factors: Potential targets for new modes of intervention in skin disease. Br. J. Dermatol. 131 (1994) 591-597
67. Merry P., Winyard P.G., Morris C.J., Grootveld M., and Blake D.R. Oxygen free radicals, inflammation, and synovitis: The current status. Ann. Rheum. Dis. 48 (1989) 864-870
68. Meyer M.R., Schreck R., and Baeuerle P.A. Hydrogen peroxide and antioxidants have opposite effects on activation of NFKB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
69. Morimoto R.I. Cells in stress: Transcriptional activation of heat shock genes. Science 259 (1993) 1409-1410
70. Muller C.W., Rey F.A., Sodeoka M., Verdine G.L., and Harrison S.C. Structure of the NF-KB p50 homodimer bound to DNA. Nature 373 (1995) 311-317
71. Murrell G., Francis N., and Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265 (1990) 659-665
72. Nose K., Shibanuma M., Kikuchi K., Kageyama H., Sakiyama S., and Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201 (1991) 99-106
73. Olah T., Regely K., and Mandi Y. The inhibitory effects of allopurinol on the production and cytotoxicity of tumor necrosis factor. N.-S. Arch. Pharmacol. 350 (1994) 96-99
74. Richter C., Park J.-W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6465-6467
75. Ron D., and Habener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6 (1992) 439-453
76. Rowe P.M. Beta-carotene takes a collective beating. Lancet 347 (1996) 249
77. Rupec R.A., and Baeuerle P.A. The genomic response of tumor cells to hypoxia and reoxygenation: Differential activation of transcription factors AP-1 and NF-KB. Eur. J. Biochem. 234 (1995) 632-640
78. Salmon M., and Gaston J.S.H. The role of T-lymphocytes in rheumatoid arthritis. Br. Med. Bull. 51 (1995) 332-345
79. Saran M., and Bors W. Oxygen radicals acting as chemical messengers: A hypothesis. Free Rad. Res. Commun. 7 (1989) 213-220
80. Satriano J., and Schlondorff D. Activation and attenuation of transcription factor NF-KB in mouse glomerular measangial cells in response to tumor-necrosis-factor-alpha, immunoglobulin G, and adenosine 3'/5'-cyclic monophosphate: Evidence for involvement of reactive oxygen species. J. Clin. Invest. 94 (1994) 1629-1636
81. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin A.S. Role of transcriptional activation of IKBα in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
82. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor KB: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad. Res. Commun. 17 (1992) 221-237
83. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-KB transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
84. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267 (1992) 5317-5323
85. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., and Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12 (1993) 3095-3104
86. Segal A.W. Components of the microbicidal oxidase of phagocytes. Biochem. Soc. Trans. 49 (1991) 49-50
87. Snyder S.H. No endothelial NO. Nature 377 (1995) 196-197
88. Staal F.J.T., Roederer M., and Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor KB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9943-9947
89. Stein B., and Yang M.X. Repression of the interleukin-6 promotor by estrogen receptor is mediated by NF-KB and CIEBPP. Mol. Cell. Biol. 15 (1995) 4971-4979
90. Suitters A.J., Foulkes R., Opal S.M., Palardy J.E., Emtage J.S., Rolfe M., Stephens S., Morgan A., Holt A.R., Chaplin L.C., Shaw N.E., Nesbitt A.M., and Bodmer M.W. Differential effect of isotype on efficacy of anti-tumor necrosis factor α chimeric antibodies in experimental septic shock. J. Exp. Med. 179 (1994) 849-856
91. Tasinato A., Boscoboinik D., Bartoli G.-M., Maroni P., and Azzi A. d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12190-12194
92. Toledano M.B., and Leonard W.J. Modulation of transcription factor NF-KB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4328-4332
93. Traenckner E.B.-M., Wilk S., and Baeuerle P.A. A proteasome inhibitor prevents activation of NF-KB and stabilises a newly phosphorylated form of IKB-α that is still bound to NF-KB. EMBO J. 13 (1994) 5433-5441
94. Vane J. Towards a better aspirin. Nature 367 (1994) 215-216
95. Whisler R.L., Goyette M.A., Grants I.S., and Newhouse Y.G. Sublethal levels of oxidant stress stimulate multiple serine threonine kinases and suppress protein phosphatases in Jurkat T-cells. Arch. Biochem. Biophys. 319 (1995) 23-35
96. Williams R.J.P. The necessary and the desirable production of radicals in biology. Phil. Trans. Roy. Soc. Lond. B 311 (1985) 593-603
97. Willis D., Moore A.R., Frederick R., and Willoughby D.A. Heme oxygenase: A novel target for the modulation of the inflammatory response. Nature Med. 2 (1996) 87-90
98. Winyard P.G., Zhang Z., Chidwick K., Blake D.R., Carrell R.W., and Murphy G. Proteolytic inactivation of human a,antitrypsin by human stromelysin. FEBS Lett. 279 (1991) 91-94
99. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J. 313 (1996) 17-29
100. Yang J.P., Merin J.P., Nakano T., Kato T., Kitade Y., and Okamoto T. Inhibition of the DNA-binding activity of NF-KB by gold compounds in vitro. FEBS Lett. 361 (1995) 89-96
101. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., and Matsushima K. Tumor necrosis factor α and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-KB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267 (1992) 22506-22511
102. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J.L., and Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15. Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87 (1991) 1146-1152
103. Yodoi J., and Uchiyama T. Diseases associated with HTLV-I: Virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today 13 (1992) 405-410